Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 19, 2015
- Accepted for publication January 29, 2016
- Published online August 1, 2016.
Article Versions
- previous version (February 16, 2016 - 07:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Christopher C. Rowe1,2,
- Gareth Jones1,
- Vincent Doré1,3,
- Svetlana Pejoska1,
- Laura Margison1,
- Rachel S. Mulligan1,
- J. Gordon Chan1,
- Kenneth Young1 and
- Victor L. Villemagne1,2,4
- 1Department of Molecular Imaging, Austin Health, Melbourne, Australia
- 2Department of Medicine, University of Melbourne, Melbourne, Australia
- 3CSIRO Health and Biosecurity, Brisbane, Australia; and
- 4Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
- For correspondence or reprints contact: Christopher C. Rowe, Department of Molecular Imaging, Austin Health, 145 Studley Rd., Heidelberg, Melbourne, Victoria 3084, Australia. E-mail: Christopher.rowe{at}austin.org.au
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- A head-to-head comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials
- Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimers Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Concordance between amyloid-PET quantification and real-world visual reads: results from IDEAS
- Alignments between cortical neurochemical systems, proteinopathy and neurophysiological alterations along the Alzheimers disease continuum
- Alzheimers Disease biological PET staging using plasma p217+tau
- The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
- Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum
- First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis
- Plasma p-tau181/A{beta}1-42 ratio predicts A{beta}-PET status and correlates with CSF-p-tau181/A{beta}1-42 and future cognitive decline
- The heritability of amyloid burden in older adults: the Older Australian Twins Study
- Plasma p217+tau vs NAV4694 amyloid and MK6240 tau PET across the Alzheimer continuum
- Association of {beta}-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals
- Association of deficits in short-term learning and A{beta} and hippocampal volume in cognitively normal adults
- Association of education with A{beta} burden in preclinical familial and sporadic Alzheimer disease
- PET Amyloid Analyses